Indivior Pharmaceuticals (INDV) Enterprise Value (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Enterprise Value of -$175.0 million for Q1 2026, up 53.08% year-over-year from -$114.3 million in Q1 2025, and up 10.26% quarter-over-quarter from -$195.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Enterprise Value (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Enterprise Value history runs 6 years deep, the most recent figure standing at -$175.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 53.08% year-over-year to -$175.0 million; the TTM figure through Mar 2026 stood at -$175.0 million (up 53.08% YoY), while the FY2025 annual figure was -$195.0 million, up 39.06% from the prior year.
- Enterprise Value for Q1 2026 stood at -$175.0 million, up from -$195.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$175.0 million in Q1 2026, with the low at -$893.0 million in Q4 2022.
- The 5-year median for Enterprise Value is -$391.5 million (2023), against an average of -$415.1 million.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value grew 18.97% in 2022, then surged 54.09% in 2023.
- Indivior Pharmaceuticals' Enterprise Value stood at -$893.0 million in 2022, then jumped by 54.09% to -$410.0 million in 2023, then rose by 21.95% to -$320.0 million in 2024, then jumped by 39.06% to -$195.0 million in 2025, then gained by 10.26% to -$175.0 million in 2026.
- Business Quant data shows INDV's Enterprise Value at -$175.0 million in Q1 2026, -$195.0 million in Q4 2025, and -$445.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.53 Bn | 4.31 Bn | 294.00 Mn | -222.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -222.00 Mn |
| Mar 31, 2026 | -175.00 Mn |
| Dec 31, 2025 | -195.00 Mn |
| Sep 30, 2025 | -445.00 Mn |
| Jun 30, 2025 | -510.00 Mn |
| Mar 31, 2025 | -373.00 Mn |
| Dec 31, 2024 | -320.00 Mn |
| Dec 31, 2023 | -410.00 Mn |
| Dec 31, 2022 | -893.00 Mn |
| Dec 31, 2021 | -1.10 Bn |